- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
本帖最后由 StephenW 于 2020-9-28 18:14 编辑
| EDP-514, a Novel Pangenotypic Class II Hepatitis B Virus Core Inhibitor: Final Resultsof a Phase 1 Study in Healthy Adult Subjects
| | | EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Kajal Larson1, Alaa Ahmad1, Eoin Coakley1, Ty McClure1, Jingwen Chai1, Daniel Dickerson2, and Nathalie Adda11Enanta Pharmaceuticals, Inc., Watertown, Massachusetts, USA; 2PRA Health Sciences -Lenexa, Lenexa, Kansas, USA
| |
| | |
|
|
|
|